209 related articles for article (PubMed ID: 23663560)
1. Expression and sub-cellular localization of an epigenetic regulator, co-activator arginine methyltransferase 1 (CARM1), is associated with specific breast cancer subtypes and ethnicity.
Davis MB; Liu X; Wang S; Reeves J; Khramtsov A; Huo D; Olopade OI
Mol Cancer; 2013 May; 12(1):40. PubMed ID: 23663560
[TBL] [Abstract][Full Text] [Related]
2. The oestrogen receptor coactivator CARM1 has an oncogenic effect and is associated with poor prognosis in breast cancer.
Habashy HO; Rakha EA; Ellis IO; Powe DG
Breast Cancer Res Treat; 2013 Jul; 140(2):307-16. PubMed ID: 23887673
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of CARM1 in breast cancer is correlated with poorly characterized clinicopathologic parameters and molecular subtypes.
Cheng H; Qin Y; Fan H; Su P; Zhang X; Zhang H; Zhou G
Diagn Pathol; 2013 Aug; 8():129. PubMed ID: 23915145
[TBL] [Abstract][Full Text] [Related]
4. A hypermethylation strategy utilized by enhancer-bound CARM1 to promote estrogen receptor α-dependent transcriptional activation and breast carcinogenesis.
Peng BL; Li WJ; Ding JC; He YH; Ran T; Xie BL; Wang ZR; Shen HF; Xiao RQ; Gao WW; Ye TY; Gao X; Liu W
Theranostics; 2020; 10(8):3451-3473. PubMed ID: 32206101
[TBL] [Abstract][Full Text] [Related]
5. TFEB, SIRT1, CARM1, Beclin-1 expression and PITX2 methylation in breast cancer chemoresistance: a retrospective study.
Bertozzi S; Londero AP; Viola L; Orsaria M; Bulfoni M; Marzinotto S; Corradetti B; Baccarani U; Cesselli D; Cedolini C; Mariuzzi L
BMC Cancer; 2021 Oct; 21(1):1118. PubMed ID: 34663249
[TBL] [Abstract][Full Text] [Related]
6. Differential CARM1 Isoform Expression in Subcellular Compartments and among Malignant and Benign Breast Tumors.
Shlensky D; Mirrielees JA; Zhao Z; Wang L; Mahajan A; Yu M; Sherer NM; Wilke LG; Xu W
PLoS One; 2015; 10(6):e0128143. PubMed ID: 26030442
[TBL] [Abstract][Full Text] [Related]
7. PELP1 oncogenic functions involve CARM1 regulation.
Mann M; Cortez V; Vadlamudi R
Carcinogenesis; 2013 Jul; 34(7):1468-75. PubMed ID: 23486015
[TBL] [Abstract][Full Text] [Related]
8. CARM1 is an important determinant of ERα-dependent breast cancer cell differentiation and proliferation in breast cancer cells.
Al-Dhaheri M; Wu J; Skliris GP; Li J; Higashimato K; Wang Y; White KP; Lambert P; Zhu Y; Murphy L; Xu W
Cancer Res; 2011 Mar; 71(6):2118-28. PubMed ID: 21282336
[TBL] [Abstract][Full Text] [Related]
9. Molecular breast cancer subtypes in premenopausal and postmenopausal African-American women: age-specific prevalence and survival.
Ihemelandu CU; Leffall LD; Dewitty RL; Naab TJ; Mezghebe HM; Makambi KH; Adams-Campbell L; Frederick WA
J Surg Res; 2007 Nov; 143(1):109-18. PubMed ID: 17950079
[TBL] [Abstract][Full Text] [Related]
10. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study.
Carey LA; Perou CM; Livasy CA; Dressler LG; Cowan D; Conway K; Karaca G; Troester MA; Tse CK; Edmiston S; Deming SL; Geradts J; Cheang MC; Nielsen TO; Moorman PG; Earp HS; Millikan RC
JAMA; 2006 Jun; 295(21):2492-502. PubMed ID: 16757721
[TBL] [Abstract][Full Text] [Related]
11. Expression of HER2 and estrogen receptor alpha depends upon nuclear localization of Y-box binding protein-1 in human breast cancers.
Fujii T; Kawahara A; Basaki Y; Hattori S; Nakashima K; Nakano K; Shirouzu K; Kohno K; Yanagawa T; Yamana H; Nishio K; Ono M; Kuwano M; Kage M
Cancer Res; 2008 Mar; 68(5):1504-12. PubMed ID: 18316615
[TBL] [Abstract][Full Text] [Related]
12. A chemical probe of CARM1 alters epigenetic plasticity against breast cancer cell invasion.
Cai XC; Zhang T; Kim EJ; Jiang M; Wang K; Wang J; Chen S; Zhang N; Wu H; Li F; Dela Seña CC; Zeng H; Vivcharuk V; Niu X; Zheng W; Lee JP; Chen Y; Barsyte D; Szewczyk M; Hajian T; Ibáñez G; Dong A; Dombrovski L; Zhang Z; Deng H; Min J; Arrowsmith CH; Mazutis L; Shi L; Vedadi M; Brown PJ; Xiang J; Qin LX; Xu W; Luo M
Elife; 2019 Oct; 8():. PubMed ID: 31657716
[TBL] [Abstract][Full Text] [Related]
13. CARM1 regulates estrogen-stimulated breast cancer growth through up-regulation of E2F1.
Frietze S; Lupien M; Silver PA; Brown M
Cancer Res; 2008 Jan; 68(1):301-6. PubMed ID: 18172323
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Breast Cancer Molecular Features and Survival by African and European Ancestry in The Cancer Genome Atlas.
Huo D; Hu H; Rhie SK; Gamazon ER; Cherniack AD; Liu J; Yoshimatsu TF; Pitt JJ; Hoadley KA; Troester M; Ru Y; Lichtenberg T; Sturtz LA; Shelley CS; Benz CC; Mills GB; Laird PW; Shriver CD; Perou CM; Olopade OI
JAMA Oncol; 2017 Dec; 3(12):1654-1662. PubMed ID: 28472234
[TBL] [Abstract][Full Text] [Related]
15. Distribution of molecular breast cancer subtypes among Algerian women and correlation with clinical and tumor characteristics: a population-based study.
Cherbal F; Gaceb H; Mehemmai C; Saiah I; Bakour R; Rouis AO; Boualga K; Benbrahim W; Mahfouf H
Breast Dis; 2015; 35(2):95-102. PubMed ID: 25736840
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic Regulation of Cardiomyocyte Maturation by Arginine Methyltransferase CARM1.
Garbutt TA; Wang Z; Wang H; Ma H; Ruan H; Dong Y; Xie Y; Tan L; Phookan R; Stouffer JA; Vedantham V; Yang Y; Qian L; Liu J
Circulation; 2024 May; 149(19):1501-1515. PubMed ID: 38223978
[TBL] [Abstract][Full Text] [Related]
17. Translational Epidemiology: An Integrative Approach to Determine the Interplay Between Genetic Ancestry and Neighborhood Socioeconomic Status on Triple Negative Breast Cancer.
Goel N; Yadegarynia S; Kwon D; Kesmodel SB; Harbour JW; Kobetz E; Merchant N; Rodriguez DA
Ann Surg; 2022 Sep; 276(3):430-440. PubMed ID: 35758508
[TBL] [Abstract][Full Text] [Related]
18. Involvement of arginine methyltransferase CARM1 in androgen receptor function and prostate cancer cell viability.
Majumder S; Liu Y; Ford OH; Mohler JL; Whang YE
Prostate; 2006 Sep; 66(12):1292-301. PubMed ID: 16705743
[TBL] [Abstract][Full Text] [Related]
19. Mortality risk of black women and white women with invasive breast cancer by hormone receptors, HER2, and p53 status.
Ma H; Lu Y; Malone KE; Marchbanks PA; Deapen DM; Spirtas R; Burkman RT; Strom BL; McDonald JA; Folger SG; Simon MS; Sullivan-Halley J; Press MF; Bernstein L
BMC Cancer; 2013 May; 13():225. PubMed ID: 23642215
[TBL] [Abstract][Full Text] [Related]
20. Ligand-dependent activation of the farnesoid X-receptor directs arginine methylation of histone H3 by CARM1.
Ananthanarayanan M; Li S; Balasubramaniyan N; Suchy FJ; Walsh MJ
J Biol Chem; 2004 Dec; 279(52):54348-57. PubMed ID: 15471871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
